0001037646 false 0001037646 2024-01-10 2024-01-10

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): | January 10, 2024

Mettler-Toledo International Inc
(Exact name of registrant as specified in its charter)

Delaware |  | File No. | 001-13595 |  | 13-3668641
(State or other jurisdiction of incorporation) |  | (Commission File Number) |  | (IRS Employer Identification No.)

1900 Polaris Parkway |  |  |
Columbus | OH |  |  |
and Im Langacher, P.O. Box MT-100 CH Greifensee, Switzerland |  | 43240 | and 8606
(Address of principal executive offices) |  | (Zip Code)

Registrant’s telephone number, including area code: 1-614-438-4511 and +41-44-944-22-11

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ |  | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ |  | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ |  | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ |  | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class | Trading Symbol | Name of each exchange on which registered
Common Stock, $0.01 par value | MTD | New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2). Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13 (a) of the Exchange Act. ☐

Item 2.02. Results of Operations and Financial Condition.
To the extent information in Item 7.01 of this Current Report on Form 8-K (including Exhibit 99.1) relates to a completed fiscal period, such information is incorporated by reference into this Item 2.02.
Item 7.01. Regulation FD Disclosure.
As previously announced, Mettler-Toledo International Inc. (the “Company”) will be presenting at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10 at 11:15 a.m. Eastern Time. The presentation materials, which include new financial information about the Company’s quarter ended December 31, 2023, are attached hereto as exhibit 99.1. The presentation materials can also be found on the investor relations page of the Company’s website (www.mt.com). A live webcast of the presentation will be available on the Company’s investor relations website.
The information in Item 2.02 and Item 7.01, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01. Financial Statements and Exhibits.

Exhibit No. | Description
99.1 | Press release, dated January 10, 2024, issued by Mettler-Toledo International Inc.
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document).*
| *Submitted electronically with this Report in accordance with the provisions of Regulation S-T.

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

| METTLER-TOLEDO INTERNATIONAL INC.
Date: January 10, 2024 | By: | /s/ Michelle M. Roe
|  | Michelle M. Roe
|  | General Counsel